<DOC>
	<DOCNO>NCT00319215</DOCNO>
	<brief_summary>The primary purpose study investigate effect bedtime administration single dose ramelteon ( 8 mg ) , zopiclone ( 7.5 mg ) , placebo next-morning on-road driving performance . In addition , drug ' effect balance evaluate night , next morning residual effect memory psychomotor performance .</brief_summary>
	<brief_title>Effects Ramelteon Driving Ability</brief_title>
	<detailed_description />
	<mesh_term>Zopiclone</mesh_term>
	<criteria>1 . The subject male female , 21 55 year age , inclusive 2 . The subject capable understanding comply protocol requirement . 3 . The subject subject ’ legally acceptable representative sign write , informed consent form prior initiation study procedure . 4 . The subject , female , nonpregnant nonlactating . 5 . Possession valid driver ’ license least 3 year report history drive least 5000 km per year average , last 3 year prior enter trial . 6 . An SDLP level end drive test dress rehearsal exceed 24 cm . This dress rehearsal perform Visit 1 . 1 . The subject know hypersensitivity ramelteon , zopiclone related compound , include melatonin . 2 . The subject participate investigational study and/or take investigational drug within 30 day five halflives prior first night doubleblind study medication , whichever longer . 5.History presence clinically significant gastrointestinal , cardiovascular , hepatic , renal , haematological , endocrine , respiratory , neurological psychiatric disease 6.History primary insomnia ( DSM IVTR criterion ) within past 6 month . 7.The subject use medication psychotropic effect ( e.g . antidepressant , anxiolytic , antihistamine ) within 30 day initial visit .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2007</verification_date>
	<keyword>ramelteon</keyword>
	<keyword>zopiclone</keyword>
	<keyword>drive</keyword>
	<keyword>memory</keyword>
	<keyword>balance</keyword>
	<keyword>psychomotor</keyword>
</DOC>